Clinical trial

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

NCT03199560

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-06-22

PhasePHASE4

Study timeline

Study start (actual)2017-06-22Date precision: day

Registry last updated2018-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Sentinel Lymph Node Biopsyunresolved

Breast Cancerunresolved

Interventions

Tc 99m tilmanoceptDRUG

Tc 99m filtered sulfur colloidDRUG

Sponsors & collaborators

Memorial Health University Medical Centerlead sponsor

Mapped research locations

SavannahGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03199560 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.